數位治療 (DTx) 市場規模、佔有率、收益分析、按產品、按收益模式、按應用、按分銷管道、按地區 - 行業預測，2024-2031 年

數位治療（DTx）的全球市場規模將於2022年達到34.4億美元，預測期內（2024-2031年）複合年成長率為16.61%，從2023年到2031年的40.1億美元。美國137.2 億美元。

由於醫療保健技術的進步和慢性病盛行率的增加，全球數位治療（DTx）市場正在迅速擴大。數位療法 (DTx) 是軟體驅動的主導，旨在透過基於證據和臨床檢驗的治療來治療或管理醫療狀況。這些解決方案用於管理各種健康狀況，包括糖尿病、心血管疾病、呼吸道疾病和心理健康問題。替代或補充傳統藥物治療的治療方法，通常著重於行為改變、遠端監測和患者教育。推動市場成長的關鍵因素包括對遠距醫療服務的需求不斷成長、行動醫療(行動醫療) 技術的日益採用以及基於價值的醫療保健模式的接受度不斷提高。提高患者對數位療法 (DTx) 治療通訊協定的依從性，並提供即時資料見解，幫助個人更有效地管理自己的健康。政府和醫療保健提供者越來越認知到 DTx 在降低醫療成本和改善患者治療效果方面的潛力。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 市場生態系統
• 主要投資分析
• 關鍵成功因素
• 競爭程度
• 技術分析
• 價值鏈分析
• 研發線產品分析
• 案例研究分析
• 監管環境
• 價格分析
• 專利分析

數位治療 (DTx) 市場：依產品分類

• 市場概況
• 軟體/平台
• 程式
• 虛擬實境/遊戲

數位治療 (DTx) 市場：按應用分類

• 市場概況
• 治療/護理相關應用
  • 糖尿病
  • 中樞神經系統 (CNS) 疾病
  • 精神疾病
  • 其他中樞神經系統疾病
  • 禁止抽煙
  • 慢性呼吸道疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 用藥依從性
  • 胃腸道疾病
  • 復健和患者照護
  • 物質使用疾患與成癮管理
  • 其他治療/護理相關用途
• 預防性使用
  • 糖尿病前期
  • 肥胖
  • 營養
  • 生活方式管理
  • 其他預防用途

數位治療 (DTx) 市場：按收益模式分類

• 市場概況
• 基於訂閱的模式
• 一次性購買/年度授權模式
• 基於結果/價值的模型

數位治療 (DTx) 市場：按銷售管道

• 市場概況
• B2B銷售管道
  • 付款人
  • 雇主
  • 製藥公司
  • 提供者
  • 其他買家
• B2C銷售管道
  • 看護者
  • 病人

數位治療 (DTx) 市場規模：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• ANSYS（US）
• Dassault Systemes（SIMULIA）（France）
• PTC（Creo）（US）
• Siemens Digital Industries Software（Simcenter）（Germany）
• Autodesk（Simulation）（US）
• OpenFOAM（Open-source）（N/A）
• STAR-CCM+（US/Germany）
• COMSOL Multiphysics（Sweden）
• CD-adapco（STAR-CD, STAR-CCM+）（US/Germany）
• Altair（HyperWorks）（US）
• ESI Group（France）
• MSC Software（MSC Adams, MSC Marc）（US）
• MathWorks（MATLAB/Simulink）（US）
• Flow3D（US）
• Fluent（US）
• CONVECTION（US）
• Cadence Design Systems（US）
• Synopsys（US）
• Numerica（US）
• Pointwise（US）

Global Digital Therapeutics Market size was valued at USD 3.44 billion in 2022 and is poised to grow from USD 4.01 billion in 2023 to USD 13.72 billion by 2031, at a CAGR of 16.61 % during the forecast period (2024-2031).

Global digital therapeutics market is expanding rapidly, driven by technological advancements in healthcare and the increasing prevalence of chronic diseases. Digital therapeutics (DTx) are software-driven interventions designed to treat or manage medical conditions through evidence-based, clinically validated therapies. These solutions are used to manage a variety of health conditions, including diabetes, cardiovascular diseases, respiratory disorders, and mental health issues. They offer an alternative or complement to traditional drug treatments, often focusing on behavior modification, remote monitoring, and patient education. Key factors contributing to market growth include the rising demand for remote healthcare services, the increasing adoption of mobile health (mHealth) technologies, and the growing acceptance of value-based healthcare models. Digital therapeutics improve patient adherence to treatment protocols, provide real-time data insights, and empower individuals to manage their health more effectively. Governments and healthcare providers are increasingly recognizing the potential of DTx in reducing healthcare costs and improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Therapeutics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Therapeutics Market Segmental Analysis

Global digital therapeutics market is segmented on the basis of offering, revenue model, application, sales channel, and region. By offering, market is segmented into software/platforms, programs, virtual reality/games. By revenue model, market is segmented into subscription-based model, one-time purchase/annual licensing model, and outcome /value-based model. By application, market is segmented into treatment/care-related applications, and preventive applications. By distribution channel, market is segmented into B2B sales channel, and B2C sales channel. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital Therapeutics Market

The growing prevalence of chronic diseases is a major driver for the digital therapeutics market. Conditions like diabetes, cardiovascular diseases, and obesity require continuous monitoring and management, often placing a strain on healthcare systems. Digital therapeutics offer a solution by providing personalized, scalable, and data-driven treatment plans that patient can access remotely. For example, mobile apps designed for diabetes management help patients track their glucose levels, adjust their diet, and maintain their medication schedule. As chronic diseases become more widespread due to aging populations and lifestyle factors, healthcare systems are turning to digital therapeutics as a cost-effective and efficient means to manage patient care. These tools not only help in monitoring the patient's condition but also support behavioral changes necessary for long-term disease management. By offering patients real-time feedback and continuous access to healthcare services, digital therapeutics are proving to be a valuable resource for managing chronic conditions.

Restraints in the Global Digital Therapeutics Market

One of the significant restraints in the digital therapeutics market is the complexity of the regulatory environment. Unlike traditional drugs and medical devices, digital therapeutics often fall into new or ambiguous categories, making it difficult for regulatory agencies like the FDA and EMA to establish clear approval guidelines. This regulatory uncertainty can delay product approvals and market entry, leading to longer development timelines and increased costs for companies. Moreover, the global nature of digital therapeutics presents additional challenges, as regulatory frameworks vary significantly from country to country. While some regions have established policies for digital health technologies, others are still developing regulatory mechanisms, creating hurdles for companies seeking to expand internationally. Concerns over patient data privacy, security, and compliance with healthcare regulations such as HIPAA also add to the complexity, making regulatory barriers one of the primary challenges in the market.

Market Trends of the Global Digital Therapeutics Market

The integration of artificial intelligence (AI) and machine learning (ML) technologies is a major trend in the digital therapeutics market. AI and ML enhance the capability of digital therapeutics by enabling the analysis of large volumes of patient data, thus facilitating more personalized treatment plans. These technologies can predict patient outcomes, optimize treatment regimens, and provide real-time interventions based on patient behavior and health metrics. For instance, AI-powered platforms for mental health can dynamically adjust therapy sessions based on patient responses, while AI in diabetes management tools can predict glucose level fluctuations and offer personalized recommendations. The ability to harness real-time data and predictive analytics improves the efficacy of digital therapeutics, making them more responsive to individual patient needs. As AI and ML technologies continue to advance, they are expected to further drive innovation and growth in the digital therapeutics sector, enhancing patient care and clinical outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Technology Analysis
• Value Chain Analysis
• Pipeline Products Analysis
• Case Study Analysis
• Regulatory Landscape
• Pricing Analysis
• Patent Analysis

Digital Therapeutics Market by Offering

• Market Overview
• Software/Platforms
• Programs
• Virtual Reality/Games

Digital Therapeutics Market by Application

• Market Overview
• Treatment/Care-Related Applications
  • Diabetes
  • Central Nervous System (CNS) Disorders
  • Mental Health Disorders
  • Other CNS Disorders
  • Smoking Cessation
  • Chronic Respiratory Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Medication Adherence
  • Gastrointestinal Disorders
  • Rehabilitation & Patient Care
  • Substance Use Disorders & Addiction Management
  • Other Treatment/Care-Related Applications
• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications

Digital Therapeutics Market by Revenue Model

• Market Overview
• Subscription-Based Model
• One-Time Purchase/Annual Licensing Model
• Outcome /Value-Based Model

Digital Therapeutics Market by Sales Channel

• Market Overview
• B2B Sales Channel
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Providers
  • Other Buyers
• B2C Sales Channel
  • Caregivers
  • Patients

Digital Therapeutics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• ANSYS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes (SIMULIA) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTC (Creo) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Digital Industries Software (Simcenter) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autodesk (Simulation) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenFOAM (Open-source) (N/A)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STAR-CCM+ (US/Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COMSOL Multiphysics (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD-adapco (STAR-CD, STAR-CCM+) (US/Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altair (HyperWorks) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ESI Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSC Software (MSC Adams, MSC Marc) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MathWorks (MATLAB/Simulink) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flow3D (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluent (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONVECTION (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadence Design Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synopsys (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Numerica (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pointwise (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments